Demographics, prior therapies and reasons for cemiplimab treatment: Prospective cemiplimAb-rwlc survivorship and epidemiology (CASE) study in patients with advanced cutaneous squamous cell carcinoma (CSCC)-MedSci.cn

Demographics, prior therapies and reasons for cemiplimab treatment: Prospective cemiplimAb-rwlc survivorship and epidemiology (CASE) study in patients with advanced cutaneous squamous cell carcinoma (CSCC)

Rabinowits, G; Homsi, J; Nikanjam, M; Gentry, R; Strasswimmer, J; Venna, S; Migden, MR; Chandra, S; Ruiz, E; Zhang, HR; McGinniss, J; Seluzhytsky, A; Desai, J

ANNALS OF ONCOLOGY, 2020; 31 (): S741

科室
- - 订阅+
  - 更多科室
工具
服务